We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA Nanotechnology Boosts Sensitivity of Test Strips

By LabMedica International staff writers
Posted on 21 Apr 2025

Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). More...

These tests are used to quickly detect biomarkers that indicate the presence of specific pathogens or health conditions. Due to their simplicity and cost-effectiveness, rapid tests are widely used for point-of-care diagnostics. However, traditional test strips often struggle to detect essential biomarkers that exist in very small amounts in blood, saliva, or urine. This limitation can result in critical conditions, such as strokes or heart attacks, going undiagnosed in their early stages, even though fast medical intervention is crucial for a favorable recovery. Now, researchers have significantly improved conventional test strips by using DNA origami to create a nanoscale amplifier, enabling the amplification of signals from biomarkers, which can now be enhanced up to 125 times.

A research team from Ludwig Maximilian University of Munich (Munich, Germany) has enhanced these tests by employing DNA origami, an advanced nanotechnology. In DNA origami, DNA is folded—much like the Japanese art of paper folding—into nanoscale structures that can take nearly any shape. The researchers used this technology to build a nanoscale amplifier, which dramatically boosts the sensitivity of LFIAs. Their findings, published in Nature Communications, detail how this approach improves the detection of various biomarkers, such as the heart attack marker cardiac troponin I (cTnI) and the stroke marker neurofilament light chain (NfL).

The new signal amplification system, based on DNA nanotechnology, acts as a molecular amplifier by linking detection antibodies to a precise number of signal-generating labels. This method enhances sensitivity by up to 125 times. It is adaptable to various biomarkers and sample types, including drugs of abuse, making it a flexible solution for improving existing rapid tests. According to the research team, this innovation will pave the way for more sensitive, rapid, and accessible diagnostic tools for both clinical and home-based testing. Additionally, the cost of the molecular amplifier is estimated to be about one cent per test.

“Our technology allows for unparalleled control over the amplification factor, making LFIA tests more reliable and effective for clinical applications,” said lead author Dr. Heini Ijäs. “This innovation has the potential to transform diagnostic testing across a broad range of diseases.”


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.